Liver disease is consistently associated with heavy alcohol consumption, but studies of non-heavy alcohol use on liver health are often contradictory, both within the general population and among those known to have non-alcoholic ...
Dec 8, 2022
0
2
A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers ...
Nov 18, 2022
0
951
Context is known to influence many spheres. And now, researchers from Japan have found that a patients' health context—that is, the other conditions a patient has—can determine whether a specific gene mutation is helpful ...
Nov 17, 2022
0
37
Almost all liver cancers develop after decades of chronic liver disease, but a new discovery by Columbia researchers may lead to treatments that could break the link.
Oct 21, 2022
0
478
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. In Germany, there are currently around 9,000 new HCC diagnoses per year, and almost 8,000 people affected do not survive the disease. Before the ...
Oct 19, 2022
0
57
WEHI researchers have revealed that common liver diseases are not driven by inflammatory cell death as previously thought, resolving a long-standing controversy in gastroenterology and pointing to a new direction for treatment.
Oct 6, 2022
0
58
The liver is the all-important organ behind processing of various substances we put into our bodies, from food and drink to alcohol and drugs. When things go awry with the liver, the consequences can be deadly. At the root ...
Sep 26, 2022
0
38
A team of scientists led by Duke-NUS Medical School have identified an important pathway that gets disrupted in the advanced form of non-alcoholic fatty liver disease known as non-alcoholic steatohepatitis (NASH)—and intervening ...
Sep 21, 2022
0
48
The prevalence of non-alcoholic fatty liver disease (NAFLD), one of the most widespread disorders worldwide, is expected to rise by more than 50% by 2030. Non-alcoholic fatty liver (NAFL), the initial stage of NAFLD, is associated ...
Sep 20, 2022
0
7
It has been described as a stealth killer that impacts at least one in four Australians and is rising rapidly. Disease prevalence is expected to increase by 25–50% over the next 10 years, including 15–20% in children. ...
Aug 24, 2022
0
3
